Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Nanosonics Limited ( (AU:NAN) ) is now available.
Nanosonics Limited has announced the application for quotation of 152,842 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of an employee incentive scheme, potentially enhancing employee engagement and aligning their interests with company performance, which could positively impact the company’s operational dynamics and market positioning.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, specializing in infection prevention solutions. The company is known for its innovative products that focus on reducing the risk of infection in healthcare settings.
Average Trading Volume: 634,831
Technical Sentiment Signal: Hold
Current Market Cap: A$1.27B
See more data about NAN stock on TipRanks’ Stock Analysis page.